PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 139 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $20,433,000 | -45.1% | 455,276 | -68.3% | 0.09% | -44.1% |
| Q1 2021 | $37,197,000 | +28.5% | 1,436,192 | 0.0% | 0.16% | +47.7% |
| Q4 2020 | $28,954,000 | -7.2% | 1,436,192 | -10.0% | 0.11% | -12.8% |
| Q3 2020 | $31,206,000 | -7.6% | 1,596,198 | -16.5% | 0.12% | -16.1% |
| Q2 2020 | $33,756,000 | +184.7% | 1,911,446 | +13.8% | 0.15% | +104.1% |
| Q1 2020 | $11,855,000 | +43.2% | 1,679,164 | +43.0% | 0.07% | +65.9% |
| Q4 2019 | $8,279,000 | -41.3% | 1,174,282 | 0.0% | 0.04% | -54.2% |
| Q3 2019 | $14,103,000 | +17.0% | 1,174,282 | +18.0% | 0.10% | +17.1% |
| Q2 2019 | $12,050,000 | +137.3% | 995,082 | +146.4% | 0.08% | +156.2% |
| Q1 2019 | $5,077,000 | – | 403,893 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,446,874 | $154,696,000 | 18.62% |
| Johnson & Johnson Innovation - JJDC, Inc. | 2,449,183 | $109,919,000 | 11.24% |
| BVF INC/IL | 3,754,095 | $168,484,000 | 6.32% |
| Tri Locum Partners LP | 341,650 | $15,333,000 | 5.02% |
| Twin Lakes Capital Management, LLC | 143,440 | $6,438,000 | 3.58% |
| COMMODORE CAPITAL LP | 210,600 | $9,452,000 | 3.29% |
| Altium Capital Management LP | 282,445 | $12,676,000 | 2.94% |
| Pinz Capital Management, LP | 196,000 | $8,796,000 | 2.65% |
| Opaleye Management Inc. | 330,222 | $14,820,000 | 2.46% |
| RTW INVESTMENTS, LP | 3,507,390 | $157,412,000 | 2.38% |